Resverlogix Announces Fourth Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone Jun 29, 2017
AGIC Capital To Acquire US Pharmaceutical Firm Ritedose For Asian Expansion Jun 26, 2017 Life Science
DelMar Pharmaceuticals Receives Institutional Review Board Approval for Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM Jun 23, 2017 Life Science
Chi-Med Initiates a Phase I/II Clinical Trial of Novel FGFR Inhibitor HMPL 453 in China Jun 22, 2017 Life Science
DelMar Presents Poster of Clinical Research with VAL-083 in Patients with Chemo-resistant Glioblastoma (“GBM”) at SNO’s Pediatric Neuro-Oncology Basic and Translational Research Conference Jun 17, 2017 Life Science
RedHill Biopharma Announces Confirmatory Phase III Study Initiated with RHB-105 (TALICIA™) for H. pylori Infection Jun 15, 2017 Life Science
ACEA Biosciences Announces Successful Completion of Phase I Clinical Study of Novel Autoimmune Disease Drug Jun 14, 2017 Life Science
RedHill Biopharma Initiates Promotion of Donnatal® and EnteraGam® in the U.S Jun 14, 2017 Life Science
RedHill Biopharma Announces Successful Phase III Top-Line Results with BEKINDA® for Acute Gastroenteritis Jun 14, 2017 Life Science
